Send us a text

Summary:  Like it’s never happened before, the FDA approval of a new weight loss drug grabbed the headlines, but here’s another headline:  Same Stuff, Different Packaging – Zepbound.  This episode is a review of this very effective and very popular group of new drugs:  the Ozempic-like drugs, the Incretin Mimetics, which act like the gut hormones secreted in response to food.  The idea here is to provide a broader perspective on this group of drugs, so you might understand what is happening now, and perhaps you will not be surprised by what may happen in the future.  Whether it's coincidence or a subtle nod to Zepbound's intended use, it will be available shortly after Thanksgiving.

 Topics:

·       Diabetes – Weight Loss 03:00

·       Hormones 04:00

·       Incretins 04:30

·       New Drugs in Same Class 08:00

·       Zepbound Mechanisms of Action 10:50

·       Zepbound Side Effects 12:00

·       Zepbound Indications – BMI 13:30

·       Zepbound Effective? Yes 14:30

·       Semaglutide: Ozempic-Wegovy 16:30

        Liraglutide: Victoza – Saxenda 

        Terzepatide:  Mounjaro – Zepbound

·       With Exercise & Diet 18:30

·       Rybelsus (Semaglutide) - Oral 19:30

·       Document-Monitor-Participate 20:00

·       Post-Marketing Monitoring – MedWatch (FDA) 20:45

Questions and comments to [email protected]